Hexagon Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
56,446
+716
| +1% | +$17.4K | 0.3% | 27 |
|
|
2025
Q1 | $1.41M | Buy |
55,730
+2,307
| +4% | +$58.5K | 0.27% | 35 |
|
|
2024
Q4 | $1.42M | Buy |
53,423
+889
| +2% | +$23.6K | 0.26% | 32 |
|
|
2024
Q3 | $1.52M | Buy |
52,534
+1,911
| +4% | +$55.3K | 0.3% | 24 |
|
|
2024
Q2 | $1.42M | Buy |
50,623
+11,088
| +28% | +$310K | 0.31% | 25 |
|
|
2024
Q1 | $1.1M | Sell |
39,535
-1,627
| -4% | -$45.1K | 0.24% | 35 |
|
|
2023
Q4 | $1.19M | Buy |
41,162
+3,101
| +8% | +$89.3K | 0.29% | 27 |
|
|
2023
Q3 | $1.26M | Buy |
38,061
+387
| +1% | +$12.8K | 0.33% | 23 |
|
|
2023
Q2 | $1.38M | Buy |
37,674
+2,814
| +8% | +$103K | 0.36% | 22 |
|
|
2023
Q1 | $1.42M | Buy |
34,860
+4,753
| +16% | +$194K | 0.4% | 21 |
|
|
2022
Q4 | $1.54M | Sell |
30,107
-3,306
| -10% | -$169K | 0.45% | 13 |
|
|
2022
Q3 | $1.46M | Buy |
33,413
+11,009
| +49% | +$482K | 0.43% | 17 |
|
|
2022
Q2 | $1.18M | Buy |
22,404
+1,745
| +8% | +$91.5K | 0.35% | 32 |
|
|
2022
Q1 | $1.07M | Sell |
20,659
-253
| -1% | -$13.1K | 0.28% | 41 |
|
|
2021
Q4 | $1.24M | Buy |
20,912
+1,257
| +6% | +$74.2K | 0.32% | 35 |
|
|
2021
Q3 | $845K | Sell |
19,655
-1,033
| -5% | -$44.4K | 0.25% | 47 |
|
|
2021
Q2 | $810K | Buy |
20,688
+305
| +1% | +$11.9K | 0.22% | 48 |
|
|
2021
Q1 | $738K | Buy |
20,383
+1,629
| +9% | +$59K | 0.2% | 45 |
|
|
2020
Q4 | $690K | Buy |
18,754
+2
| +0% | +$74 | 0.2% | 46 |
|
|
2020
Q3 | $644K | Buy |
+18,752
| New | +$644K | 0.21% | 46 |
|